Does environmental regulation indirectly induce upstream innovation? New evidence from India P Chakraborty, C Chatterjee Research Policy 46 (5), 939-955, 2017 | 230 | 2017 |
Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry L Branstetter, C Chatterjee, MJ Higgins The RAND Journal of Economics 47 (4), 857-890, 2016 | 139 | 2016 |
Gender and its rising role in modern Indian innovation and entrepreneurship C Chatterjee, S Ramu IIMB Management Review 30 (1), 62-72, 2018 | 56 | 2018 |
Ethical issues in health care sector in India C Chatterjee, V Srinivasan IIMB Management Review 25 (1), 49-62, 2013 | 52 | 2013 |
Strong medicine: Patent reform and the emergence of a research-driven pharmaceutical industry in India A Arora, L Branstetter, C Chatterjee NBER Conference on Location of Biopharmaceutical Activity, Boston, MA, 7-8, 2008 | 50 | 2008 |
Starving (or fattening) the golden goose?: generic entry and the incentives for early-stage pharmaceutical innovation L Branstetter, C Chatterjee, MJ Higgins National Bureau of Economic Research, 2014 | 46 | 2014 |
The consumer welfare implications of governmental policies and firm strategy in markets for medicines C Chatterjee, K Kubo, V Pingali Journal of Health Economics 44, 255-273, 2015 | 36 | 2015 |
Price control and access to drugs: The case of india’s malaria market D Mohapatra, C Chatterjee Working Paper. Cornell University, 2015 | 31 | 2015 |
Women’s disempowerment and preferences for skin lightening products that reinforce colorism: Experimental evidence from India A Adbi, C Chatterjee, C Cortland, Z Kinias, J Singh Psychology of Women Quarterly 45 (2), 178-193, 2021 | 27* | 2021 |
Can greater access to education be inequitable? New evidence from India’s Right to Education Act C Chatterjee, EA Hanushek, S Mahendiran National Bureau of Economic Research, 2020 | 27 | 2020 |
Mitigating regulatory impact: the case of partial price controls on metformin in India A Bhaskarabhatla, C Chatterjee, P Anurag, E Pennings Health policy and planning 32 (2), 194-204, 2017 | 27 | 2017 |
When the big one came: A natural experiment on demand shock and market structure in India's influenza vaccine markets A Adbi, C Chatterjee, M Drev, A Mishra Production and Operations Management 28 (4), 810-832, 2019 | 24 | 2019 |
Government health insurance and spatial peer effects: New evidence from India C Chatterjee, R Joshi, N Sood, P Boregowda Social Science & Medicine 196, 131-141, 2018 | 24 | 2018 |
Intellectual property regimes and wage inequality S Bhattacharya, P Chakraborty, C Chatterjee Journal of Development Economics 154, 102709, 2022 | 18 | 2022 |
Hit where it hurts: cartel policing using targeted sales and supply embargoes A Bhaskarabhatla, C Chatterjee, B Karreman The Journal of Law and Economics 59 (4), 805-846, 2016 | 18 | 2016 |
Stakeholder orientation and market impact: Evidence from India A Adbi, A Bhaskarabhatla, C Chatterjee Journal of business ethics 161, 479-496, 2020 | 16 | 2020 |
Strong medicine? Patent reform and the transformation of the Indian pharmaceutical industry A Arora, L Branstetter, C Chatterjee, K Saggi mimeo, 2009 | 15 | 2009 |
The role of physicians in prescribing irrational fixed-dose combination medicines in India A Bhaskarabhatla, C Chatterjee Social science & medicine 174, 179-187, 2017 | 13 | 2017 |
Innovation and internationalisation in the Indian software industry: Wipro–Going forward: Interview with Rishad Premji, Chief Strategy Officer, Wipro Limited C Chatterjee IIMB management Review 26 (1), 59-64, 2014 | 12 | 2014 |
Did India's price control policy for coronary stents create unintended consequences? S Deo, H Tyagi, C Chatterjee, H Molakapuri Social Science & Medicine 246, 112737, 2020 | 11 | 2020 |